MON-PP034: Oral Supplementation with the Human Milk Oligosaccharide 2'-Fucosyllactose (2'-FL) Diminishes Cognitive Impairment Induced by Systemic Administration of Bacterial Lipopolysaccharides and Modulates Glial Cell Activation in Rodent Models